Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches

Qiong Wu1, Zhiping Yang1, Yongzhan Nie1

  • 1State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

Cancer Letters
|March 25, 2014
PubMed

Insights

Multi-drug resistance (MDR) hinders cancer chemotherapy. This review explores MDR detection methods, mechanisms, and future therapeutic strategies combining novel drugs with existing treatments.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Multi-drug resistance (MDR) is a significant challenge in cancer chemotherapy.
  • Understanding MDR mechanisms and detection methods is crucial for effective treatment.

Purpose of the Study:

  • To review in vivo and in vitro approaches for MDR detection.
  • To discuss the mechanisms of MDR in cancers.
  • To explore future clinical and therapeutic applications of MDR.

Main Methods:

  • Literature review of in vivo and in vitro MDR detection methods.
  • Analysis of current understanding of MDR mechanisms.
  • Exploration of emerging therapeutic strategies targeting MDR.

Main Results:

  • MDR mechanisms are complex and not fully understood.
  • Various laboratory methods exist for MDR detection.
  • Future therapies may involve anti-cancer stem cell, anti-miRNA, and anti-epigenetic drugs.

Conclusions:

  • Future cancer treatments will likely integrate MDR-targeted therapies.
  • Development of new biomarkers and evaluation systems is essential for early MDR detection.
  • Overcoming MDR is key to improving chemotherapy success rates.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K